Melanotan II

What it is

Melanotan II is an unlicensed melanocortin-receptor agonist sold online for tanning (and sometimes for libido effects). Unlike its regulated cousins in this section, it has never been approved as a medicine — and it has a genuinely concerning documented safety record.

Composition

It is a synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (alpha-MSH). It is closely related to the approved peptides afamelanotide (Melanotan I) and bremelanotide (PT-141), which makes the contrast instructive: same family, very different regulatory and safety status.

Proposed mechanism

It activates melanocortin receptors — including MC1R, which stimulates melanin production (tanning), and MC4R, which influences sexual arousal and appetite. The tanning effect is real; that is not the issue.

Claimed benefits

A fast, convenient tan with less sun exposure, and (secondarily) libido effects. Sellers emphasise the tan and downplay the risks.

What the evidence shows

Marketing claim· human data. It is filed here not because tanning doesn’t happen — it does — but because it is marketed as a safe, convenient shortcut while a documented risk profile and a complete lack of regulatory oversight are downplayed. Published case reports link Melanotan II to changes in moles and to melanoma, to prolonged painful erections (priapism), and to serious systemic reactions including rhabdomyolysis. Regulators including the UK MHRA have specifically warned against buying and using it.

Legal & regulatory status

No Melanotan II product holds a marketing authorisation; it is an unlicensed medicine, and its sale and supply breach medicines regulations in the UK and many other countries. It should not be confused with afamelanotide (Melanotan I / Scenesse), a licensed medicine used under specialist supervision for a rare light-sensitivity condition.

Known risks & unknowns

Documented adverse effects include new and changing moles and melanoma concerns, priapism, nausea and vomiting, flushing, and — in serious cases — rhabdomyolysis and organ stress. Because it stimulates melanocytes, the skin-cancer concern is not hypothetical, and there is no monitoring around unregulated use. This is the compound in this section where the honest summary is simplest: the risks are real, the product is unlicensed, and regulators advise against it.

Sources

Frequently asked questions

Is Melanotan II safe?

It is an unlicensed product with documented safety concerns. Published case reports link it to changes in moles and melanoma, prolonged painful erections (priapism), nausea and, rarely, serious muscle breakdown (rhabdomyolysis). UK and other regulators have specifically warned against buying and using it.

Is it the same as the approved afamelanotide?

No — and this is a key distinction. Afamelanotide (Melanotan I / Scenesse) is a licensed medicine for a rare light-sensitivity condition, used under specialist supervision. Melanotan II is a different, unlicensed compound sold online for cosmetic tanning with none of that oversight.

Does it actually make you tan?

It does stimulate melanin production, so tanning claims have a real mechanism. But 'it works' is beside the point when the product is unlicensed, unmonitored for skin-cancer risk, and sold without any quality control — the risks are why regulators advise against it.

Why is this filed under 'marketing claim'?

Not because tanning doesn't occur, but because it is marketed as a safe, convenient tanning shortcut while the documented risk profile and lack of any regulatory oversight are downplayed or omitted by sellers.